/
NEOG
$9.10-$0.48 (-5.01%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$2.1B
218M shares
52-week range
$4.56 – $11.43
66% from low
Sector
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
NASDAQ
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-36.94
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $397.9M | $414.2M | $418.2M | $468.5M | $527.2M | $822.4M | $924.2M | $894.7M |
| Cost of revenue | $211.7M | $222.3M | $221.9M | $253.4M | $284.1M | $416.5M | $461.6M | $473.3M |
| Gross profit | $186.3M | $191.9M | $196.3M | $215.1M | $243.0M | $406.0M | $462.6M | $421.4M |
| Gross margin | 46.8% | 46.3% | 46.9% | 45.9% | 46.1% | 49.4% | 50.1% | 47.1% |
| R&D | $10.9M | $12.8M | $14.8M | $16.2M | $17.0M | $26.0M | $22.5M | $21.1M |
| Operating income | $70.2M | $68.1M | $67.5M | $74.2M | $58.6M | $37.5M | $77.4M | $9.4M |
| EBITDA | $90.5M | $90.6M | $90.7M | $96.3M | $83.9M | $122.3M | $182.6M | −$937.8M |
| Net income | $63.1M | $60.2M | $59.5M | $60.9M | $48.3M | −$22.9M | −$9.4M | −$1.09B |
| Net margin | 15.9% | 14.5% | 14.2% | 13.0% | 9.2% | -2.8% | -1.0% | -122.1% |
| EPS (diluted) | 0.60 | 0.57 | 0.56 | 0.57 | 0.45 | -0.12 | -0.04 | -5.03 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $849M | $0.30 | $0.25–$0.38 | 2 |
| 2028 | $843M | $0.35 | $0.32–$0.38 | 2 |
| 2029 | $809M | $0.46 | $0.44–$0.47 | 1 |
| 2030 | $832M | $0.50 | $0.48–$0.51 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Neogen Corp
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
www.neogen.com- Employees
- 1,456
- IPO / List date
- Aug 23, 1989
- HQ
- LANSING, MI
Held by traders on TradeandTell
No one on the platform currently holds NEOG.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 106,427 | $988.7K |
| Renaissance Technologiesas of 2025-12-31 | 29,539 | $206.5K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2021-06-07 | 2-for-1 |
| 2018-01-02 | 4-for-3 |
| 2013-10-31 | 3-for-2 |
| 2009-12-16 | 3-for-2 |
| 2007-09-05 | 3-for-2 |
Recent trades on TradeandTell
No one on the platform has traded NEOG yet.
